celastrol has been researched along with sphingosine kinase in 1 studies
| Studies (celastrol) | Trials (celastrol) | Recent Studies (post-2010) (celastrol) | Studies (sphingosine kinase) | Trials (sphingosine kinase) | Recent Studies (post-2010) (sphingosine kinase) |
|---|---|---|---|---|---|
| 885 | 1 | 741 | 1,660 | 4 | 978 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kim, JS; Lee, HJ; Lee, MS; Lee, SO | 1 |
1 other study(ies) available for celastrol and sphingosine kinase
| Article | Year |
|---|---|
Anti-cancer effect of pristimerin by inhibition of HIF-1α involves the SPHK-1 pathway in hypoxic prostate cancer cells.
Topics: Antineoplastic Agents; Blotting, Western; Cell Hypoxia; Cell Line, Tumor; Gene Expression Regulation, Neoplastic; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Male; Pentacyclic Triterpenes; Phosphotransferases (Alcohol Group Acceptor); Prostatic Neoplasms; Signal Transduction; Triterpenes | 2016 |